Chair and CEO Sharon Mates sold $9.1M of Intra-Cellular Therapies, Inc.

Sold$9,086,738

$75.05Price

121,073Shares

−10%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Wed, Aug 21. Filed Fri, Aug 23, 6:00 PM ET, after the close. Not investment advice.